| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 30,992 | 31,576 | 20,661 | 32,215 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 30,992 | 31,576 | 20,661 | 32,215 | | | Operating Expenses | | Research Development | 32,147 | 28,541 | 16,828 | 31,969 | | Selling General and Administrative | 3,673 | 3,677 | 605 | 4,571 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,828) | (642) | 3,228 | (4,325) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,291 | 2,192 | (2,708) | 7,546 | | Earnings Before Interest And Taxes | (537) | 1,550 | 1,035 | 4,696 | | Interest Expense | 3,155 | 3,081 | 1,306 | 1,509 | | Income Before Tax | (3,692) | (1,531) | (271) | 3,187 | | Income Tax Expense | 61 | (717) |
-
|
-
| | Minority Interest | 1,771 |
-
| 515 | 1,475 | | | | Net Income From Continuing Ops | (1,982) | (814) | (271) | 3,187 | | | Non-recurring Events | | Discontinued Operations |
-
| 171,744 | (8,387) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,982) | 170,930 | (8,658) | 3,187 | | Preferred Stock And Other Adjustments | (913) | 913 |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,895) | $171,843 | ($8,658) | $3,187 |
|
0.67% Nasdaq 0.00%
Income Statement
